Minocycline topical- BioPharmX Corporation

Drug Profile

Minocycline topical- BioPharmX Corporation

Alternative Names: BPX-01; BPX-01 1% minocycline - BioPharmX Corporation

Latest Information Update: 25 Apr 2017

Price : $50

At a glance

  • Originator BioPharmX Corporation
  • Class Amides; Antibacterials; Dimethylamines; Neuroprotectants; Small molecules; Tetracyclines
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Acne vulgaris; Rosacea

Most Recent Events

  • 29 Mar 2017 Phase-II clinical trials for Rosacea in USA (Topical) (NCT03050086)
  • 24 Mar 2017 BioPharmX completes the OPAL phase IIb trial in Acne vulgaris (In adolescents, In children, In adults) in USA (Topical) (NCT02815332)
  • 07 Mar 2017 Chemical structure information added
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top